Skip to main content
Clinical Trials/IRCT2017012232109N1
IRCT2017012232109N1
Completed
Phase 2

The clinical trial of evaluation of the effect of black cumin (nigella sativa) extract supplementation on serum levels of some inflammatory markers, liver enzymes, lipid profile ,insulin and fasting plasma glucose in patients with non-alcoholic fatty liver disease

Vice Chancellor for research of Ahvaz Jundishapur University of Medical Sciences0 sites44 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
on alcholic fatty liver.
Sponsor
Vice Chancellor for research of Ahvaz Jundishapur University of Medical Sciences
Enrollment
44
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Vice Chancellor for research of Ahvaz Jundishapur University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • patients aged 20 to 60 years diagnosed with nonalcoholic fatty liver by ultrasound, confirmed by a radiologist and a gastroenterologist.
  • Exclusion criteria: pregnancy and lactation; liver transplantation; smoking; alcohol and drug abuse; consuming drugs such as corticosteroids, amiodarone, tamoxifen, methotrexate; receiving total parenteral nutrition; rapid weight loss; diabetes; heart failure; thyroid problems; kidney disease; hereditary hemochromatosis and Wilson disease; have a positive test for hepatitis C, B and autoimmune hepatitis; alpha\-1 antitrypsin deficiency.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials